会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 86. 发明申请
    • Single label comparative hybridization
    • 单标记比较杂交
    • US20050260665A1
    • 2005-11-24
    • US11134133
    • 2005-05-19
    • Mansoor MohammedNatasa DzidicChristopher McCaskillJaeweon Kim
    • Mansoor MohammedNatasa DzidicChristopher McCaskillJaeweon Kim
    • C12Q1/68
    • C12Q1/6837C12Q1/6823C12Q1/6825C12Q1/6841C12Q1/6883C12Q2600/16C12Q2565/501C12Q2539/101C12Q2537/155C12Q2545/107
    • The present invention provides methods of detecting and mapping chromosomal or genetic abnormalities associated with various diseases or with predisposition to various diseases, or to detecting the phenomena of large scale copy number variants. In particular, the present invention provides advanced methods of performing array-based comparative hybridization that allow reproducibility between samples and enhanced sensitivity by using the same detectable label for both test sample and reference sample nucleic acids. Invention methods are useful for the detection or diagnosis of particular disease conditions such as cancer, and detecting predisposition to cancer based on detection of chromosomal or genetic abnormalities and gene expression level. Invention methods are also useful for the detection or diagnosis of hereditary genetic disorders or predisposition thereto, especially in prenatal samples. Moreover, invention methods are also useful for the detection or diagnosis of de novo genetic aberrations associated with post-natal developmental abnormalities.
    • 本发明提供了检测和映射与各种疾病相关的染色体或遗传异常或具有各种疾病倾向的方法,或者检测大规模拷贝数变体的现象。 特别地,本发明提供了进行基于阵列的比较杂交的先进方法,其通过使用相同的可检测标记用于测试样品和参照样品核酸,从而允许样品之间的再现性和增强的灵敏度。 本发明方法可用于检测或诊断特定的疾病状况如癌症,并且基于染色体或遗传异常和基因表达水平的检测来检测癌症易感性。 本发明的方法也可用于遗传性遗传疾病或其易感性的检测或诊断,特别是在产前样品中。 此外,发明方法也可用于检测或诊断与产后发育异常相关的从头遗传畸变。
    • 88. 发明申请
    • Method of quantification hiv-1rna-dna hybrid and diagnosis kit
    • 定量方法hiv-1rna-dna杂交和诊断试剂盒
    • US20040115618A1
    • 2004-06-17
    • US10416530
    • 2003-05-27
    • Shingo Kato
    • C12Q001/70C12Q001/68C12P019/34
    • C12Q1/703C12Q1/6851C12Q2549/119C12Q2545/107C12Q2521/301
    • A diagnostic kit for evaluating the progress of an HIV-1-related disease and/or the efficacy of an anti-HIV-1 treatment using the quantity of an HIV-1 RNA-DNA hybrid in a sample as an indicator, comprising: at least one primer pair consisting of a downstream primer having a sequence complementary to a portion of the nucleotide sequence of the constituent RNA of the HIV-1 RNA-DNA hybrid and an upstream primer having a sequence complementary to a portion of the nucleotide sequence of the constituent DNA of the HIV-1 RNA-DNA hybrid; and restriction enzyme by which double-stranded DNA containing the same nucleotide sequence as DNA extended by the primer pair can be cleaved at any specific site in the nucleotide sequence.
    • 一种用于评估HIV-1相关疾病进展和/或使用样品中的HIV-1 RNA-DNA杂交体的量作为指标的抗HIV-1治疗的功效的诊断试剂盒,其包括: 由具有与HIV-1 RNA-DNA杂交体的构成RNA的核苷酸序列的一部分互补的序列的下游引物组成的至少一个引物对和具有与所述HIV-1 RNA-DNA杂交体的核苷酸序列的一部分互补的序列的上游引物 HIV-1 RNA-DNA杂交体的构成DNA; 以及限制酶,通过该限制酶,可以在核苷酸序列的任何特定位点切割含有与引物对延伸的DNA相同的核苷酸序列的双链DNA。